Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.

about

Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.

Item

http://www.wikidata.org/entity/Q51804210

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.

@en

Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.

@nl

type

Item

label

Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.

@en

Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.

@nl

prefLabel

Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.

@en

Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.

@nl

P1476

Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.

@en

P2093

Gaurav Chatterjee

http://www.w3.org/2001/XMLSchema#string

Papagudi G Subramanian

http://www.w3.org/2001/XMLSchema#string

Prashant R Tembhare

http://www.w3.org/2001/XMLSchema#string

Sumeet Gujral

http://www.w3.org/2001/XMLSchema#string

P2860

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes

CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy

Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma

New criteria for response assessment: role of minimal residual disease in multiple myeloma

Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab

Smoldering multiple myeloma.

Immunophenotypic analysis of Waldenstrom's macroglobulinemia

CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms

Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition.

Immunophenotypic profile of plasma cell leukemia: a retrospective study in a reference cancer center in India and review of literature.

P2888

s12288-017-0822-z

P304

303-315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12288-017-0822-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28824230

http://www.w3.org/2001/XMLSchema#string

P932

5544653

http://www.w3.org/2001/XMLSchema#string